NEW BRUNSWICK, Nj. - Johnson & Johnson is the latest U.S. drugmaker to announce a deal with the Trump Administration to lower drug costs for customers while sidestepping costly tariffs.

Johnson & Johnson said it would participate in the government-run website TrumpRx.com, which the Trump administration said will provide consumers with “massive price reductions” when they purchase their medicines directly from the site. The company didn’t say which drugs it would offer on TrumpRx.

Since September, the White House has announced deals with 14 pharmaceutical companies, including Merck and Sanofi, to lower prescription drug prices.

Those drugmakers also will offer some of their products on TrumpRx.com, the White House said. For example, Merck will reduce the price of its diabetes medication, Januvia, from $330 to $100 for patients purchasing directly through the website; also, Sanofi will reduce the price of its prescription blood thinner, Plavix, from $756 to $16, and list its insulin products at $35 per month’s supply.